Akshay Vaishnaw, EVP, Chief Medical Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 10,626 shares at $94.40 ($995K) on 2014-12-16, disclosed to the SEC on 2014-12-16.
Scheduled sale ($995k) by EVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $91.47 | 600 | $55K | 5.5% |
| 2 | $92.33 | 1,900 | $175K | 17.6% |
| 3 | $93.42 | 2,936 | $274K | 27.6% |
| 4 | $94.40 | 5,090 | $480K | 48.3% |
| 5 | $95.00 | 100 | $10K | 1.0% |
| Total | $93.60 avg | 10,626 |
| $995K |
| 100% |
| Filing → |
| SRRK | SELL | 2025-05-30 | $353K | — | Filing → |
| ALNY | SELL | 2023-08-07 | $1.4M | — | Filing → |
| ALNY | SELL | 2023-04-28 | $839K | — | Filing → |